Trial document




drksid header

  DRKS00017790

Trial Description

start of 1:1-Block title

Title

Screening of palliative care needs in patients with incurable hematological malignancies (PallHäm_101)

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

OSHO#90

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

Palliative Care is aimed to improve quality of life in patients during the course of their incurable disease. In patients with hematological malignancies course of disease is highly variable. Goal of the study is the screening of symptoms and palliative care needs in patients with incurable blood malignancies. The Screening will be done with questionnaires.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

Prospective Screening of palliative care needs in pts. with hematological malignancies specially patient and disease associated factors. With these results a riskadapted approach for the implementation of palliative care in pts. with hematological malignancies will be developed.

end of 1:1-Block scientific synopsis
start of 1:1-Block forwarded Data

Do you plan to share individual participant data with other researchers?

[---]*

end of 1:1-Block forwarded Data
start of 1:1-Block forwarded Data Content

Description IPD sharing plan:

[---]*

end of 1:1-Block forwarded Data Content
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00017790
  •   2019/08/27
  •   [---]*
  •   yes
  •   Approved
  •   12/19, Ethik-Kommission der Ärztekammer Sachsen-Anhalt Bezirksstelle Halle
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   C81 -  Hodgkin lymphoma
  •   C82 -  Follicular lymphoma
  •   C83 -  Non-follicular lymphoma
  •   C84 -  Mature T/NK-cell lymphomas
  •   C85 -  Other and unspecified types of non-Hodgkin lymphoma
  •   C90 -  Multiple myeloma and malignant plasma cell neoplasms
  •   C91 -  Lymphoid leukaemia
  •   C92 -  Myeloid leukaemia
  •   All the above listed diseases needs to be in an incurable stage
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   One-time registration of symptoms according to modified questionnaire of the DGP at time of clinical presentation
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Non-interventional
  •   Epidemiological study
  •   Other
  •   Open (masking not used)
  •   [---]*
  •   Other
  •   Screening
  •   Other
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Evaluation of patient and disease related factors for palliative care needs in pts. with incurable hematological malignancies

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

Definition of risk groups with high palliative care needs

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2019/09/01
  •   500
  •   Multicenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   18   Years
  •   100   Years
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

incurable hematological malignancies

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

curative therapeutic option

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • c/o Sekretariat OSHO
    • Mr.  PD Dr. med.  Herbert G.  Sayer 
    • Strümpelstr. 42
    • 04289  Leipzig
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Klinik für Hämatologie, Onkologie und Palliativmedizin
    • Mr.  Prof. Dr. med.  Christoph  Kahl 
    • Birkenallee 34
    • 39130  Magdeburg
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Klinik für Hämatologie, Onkologie und Palliativmedizin
    • Ms.  Manuela  Dawid 
    • Birkenallee 34
    • 39130  Magdeburg
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • c/o Sekretariat OSHO
    • Mr.  PD Dr. med.  Herbert G.  Sayer 
    • Strümpelstr. 42
    • 04289  Leipzig
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting ongoing
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.